吸入膠囊市場：按產品類型、按應用、按病患小組、按性別、按分銷管道、按地區

Inhalation Capsules Market, By Product Type, By Application, By Patient Group, By Gender, By Distribution Channel, By Geography

出版日期: 2025年05月29日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球吸入膠囊市場規模為 9.801 億美元，到 2032 年將達到 15.244 億美元，2025 年至 2032 年的複合年成長率為 6.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	9.801億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	6.50%	2032年價值預測	15.244億美元

近年來，隨著呼吸系統疾病的日益普及以及對便捷有效的藥物輸送系統的需求不斷成長，全球吸入膠囊市場經歷了顯著成長。吸入膠囊是一種給藥方式，將藥物封裝在小巧便攜的膠囊中，並使用特定裝置吸入。這種給藥方式相較於傳統的口服和注射方法具有多種優勢，包括起效更快、靶向輸送至肺部以及減少全身暴露。吸入膠囊市場應用廣泛，從治療氣喘和慢性阻塞性肺病(COPD) 到管理過敏和其他呼吸系統疾病。隨著醫療保健產業繼續關注以患者為中心的解決方案和創新的藥物輸送技術，預計未來幾年吸入膠囊市場將大幅成長。

市場動態：

市場的主要促進因素之一是氣喘和慢性阻塞性肺病 (COPD) 等呼吸系統疾病的日益流行，這些疾病需要有效且便捷的給藥方式。此外，老年人口的成長（老年人易患呼吸系統疾病）也進一步推動了吸入膠囊的需求。此外，人們對標靶給藥益處的認知不斷提高，以及先進吸入設備的普及，也促進了市場的成長。然而，市場也存在一些限制因素，例如吸入膠囊的高昂研發和製造成本以及嚴格的核准監管要求。

此外，定量吸入器和霧化器等替代給藥方式的出現也可能對市場成長構成挑戰。儘管有這些限制因素，但隨著新興經濟體對個人化醫療、新型製劑開發和醫療基礎建設的日益重視，吸入膠囊市場仍蘊藏著巨大的成長機會。隨著製藥公司持續投資研發活動並與設備製造商合作，預計未來幾年市場將迎來創新產品的發布和策略合作夥伴關係的建立。

本研究的主要特點

本報告對全球吸入膠囊市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
全球吸入膠囊市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球吸入膠囊市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球吸入膠囊市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 980.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 1,524.4 Mn

The global inhalation capsules market has witnessed significant growth in recent years, driven by the increasing prevalence of respiratory disorders and the rising demand for convenient and effective drug delivery systems. Inhalation capsules are a type of pharmaceutical dosage form that encapsulates medication in a small, portable capsule, which is then inhaled using a specific device. This method of drug administration offers several advantages over traditional oral or injectable routes, including rapid onset of action, targeted delivery to the lungs, and reduced systemic exposure. The market for inhalation capsules encompasses a wide range of applications, from the treatment of asthma and chronic obstructive pulmonary disease (COPD) to the management of allergies and other respiratory conditions. As the healthcare industry continues to focus on patient-centric solutions and innovative drug delivery technologies, the inhalation capsules market is poised for substantial growth in the coming years.

Market Dynamics:

One of the primary drivers of the market is the increasing prevalence of respiratory disorders, such as asthma and COPD, which require effective and convenient drug delivery methods. Additionally, the growing geriatric population, who are more susceptible to respiratory ailments, further fuels the demand for inhalation capsules. Moreover, the rising awareness about the benefits of targeted drug delivery and the availability of advanced inhalation devices contribute to the market's growth. However, the market also faces certain restraints, such as the high cost of development and manufacturing of inhalation capsules, as well as the strict regulatory requirements for approval.

Furthermore, the availability of alternative drug delivery methods, such as metered-dose inhalers and nebulizers, may pose a challenge to the market's growth. Despite these restraints, the inhalation capsules market presents significant opportunities for growth, driven by the increasing focus on personalized medicine, the development of novel drug formulations, and the expansion of healthcare infrastructure in emerging economies. As pharmaceutical companies continue to invest in research and development activities and collaborate with device manufacturers, the market is expected to witness innovative product launches and strategic partnerships in the coming years.

Key features of the study:

This report provides in-depth analysis of the global inhalation capsules market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global inhalation capsules market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Teva Pharmaceutical Industries, Merck & Co., Mylan N.V., Sun Pharmaceutical Industries, Hikma Pharmaceuticals, Otsuka Pharmaceutical, Chiesi Farmaceutici, Cipla, AbbVie, and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global inhalation capsules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation capsules market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Dry Powder Inhaler
- Soft Mist Inhalers
- Nebulizer Capsules
- Pressurized Metered-Dose Inhalers
- Others (Unit-dose vials, disposable nebulizers)
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Bronchitis
- Pulmonary Fibrosis
- Cystic Fibrosis
- Other Respiratory Disorders
Patient Group Insights (Revenue, USD Mn, 2020 - 2032)
- Adults
- Paediatric
- Geriatric
Gender Insights (Revenue, USD Mn, 2020 - 2032)
- Male
- Female
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Pfizer
- Teva Pharmaceutical Industries
- Merck & Co.
- Mylan N.V.
- Sun Pharmaceutical Industries
- Hikma Pharmaceuticals
- Otsuka Pharmaceutical
- Chiesi Farmaceutici
- Cipla
- AbbVie
- Sanofi

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Inhalation Capsules Market, By Product Type
- Global Inhalation Capsules Market, By Application
- Global Inhalation Capsules Market, By Patient Group
- Global Inhalation Capsules Market, By Gender
- Global Inhalation Capsules Market, By Distribution Channel
- Global Inhalation Capsules Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Inhalation Capsules Market, By Product Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Dry Powder Inhaler
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Nebulizer Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pressurized Metered-Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Unit-dose vials, disposable nebulizers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Inhalation Capsules Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Bronchitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pulmonary Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Inhalation Capsules Market, By Patient Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Paediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Inhalation Capsules Market, By Gender, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Inhalation Capsules Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Inhalation Capsules Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa

10. Competitive Landscape

GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Otsuka Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cipla
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies